TRAUMA
Safety and efficacy of edoxaban similar to enoxaparin for hip fracture surgery
This report has been verified
by one or more authors of the
original publication.
Thromb Res. 2014 Jun;133(6):1016-22. doi: 10.1016/j.thromres.2014.03.009. Epub 2014 Mar 6.
92 patients undergoing hip fracture surgery were randomized to receive postoperative thromboprophylaxis with either oral once-daily edoxaban or once- or twice-daily subcutaneous injections of enoxaparin. This study aimed to compare the safety and efficacy between these two anticoagulant therapies. Results indicated a comparable percentage of patients with a major or clinically relevant non-major bleeding event between groups, while minor bleeding events were higher in edoxaban patients. The proportion of patients with an adverse event was similar, as was the incidence of composite thromboembolic events.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
